Jimmy Butts is the Chief Investment Strategist for Maximum Profit and Top Stock Advisor, and a regular contributor to StreetAuthority Insider. Prior to joining StreetAuthority, Jimmy came from the financial services and banking industry where he worked as a Financial Advisor. There he specialized in providing customized retirement solutions for individuals. Jimmy graduated from Boise State University with a degree in business administration and finance. He also spent multiple years studying language, international business and finance in both Germany and Buenos Aires, Argentina. He currently holds his series 6, 63, 65 and 26 securities license. When he's not combing through financial statements or reading about finance, Jimmy enjoys being outdoors.
Analyst Articles
From the outset, investing seems simple enough. But in practice, it can be much different... Read...
Read More
From the outset, investing seems simple enough. But in practice, it can be much different... Read More
Read More
About a year ago, I wrote about the merits of investing in what I called “the most enduring...
Read More
About a year ago, I wrote about the merits of investing in what I called “the most enduring assets of all-time.” The asset? Farmland, of course. Read More
Read More
Any good ship is only as powerful as its armaments. That's why we here at StreetAuthority have long...
Read More
Any good ship is only as powerful as its armaments. That's why we here at StreetAuthority have long advocated that our readers add new weapons to their trading arsenal. Read More
Read More
Fibonacci ratios are also used to define upside price targets and support levels. They can also...
Read More
Fibonacci ratios are also used to define upside price targets and support levels. They can also help identify times when a stock or index is likely to turn. Read More
Read More
Biologic drugs are a game-changer. Demand isn’t going to slow down anytime soon, and Big Pharma...
Read More
Biologic drugs are a game-changer. Demand isn’t going to slow down anytime soon, and Big Pharma needs companies like this one to continue developing innovative treatments... Read More
Read More
It's always more important to watch what investors do rather than listen to what they say... Read...
Read More
It's always more important to watch what investors do rather than listen to what they say... Read More
Read More
Make no mistake, this company was built for a single purpose: to throw off a rising stream of...
Read More
Make no mistake, this company was built for a single purpose: to throw off a rising stream of tax-advantaged rental income. Read More
Read More
The streaming wars are heating up… And no, I'm not talking about Netflix vs your cable company....
Read More
The streaming wars are heating up… And no, I'm not talking about Netflix vs your cable company. Here's why it matters -- and how you can profit... Read More
Read More
There is a chance this could move from the front page to the history books by the end of February....
Read More
There is a chance this could move from the front page to the history books by the end of February. If it's still in the news a month from now, China — and the world — will face an economic...
Read More
There are thousands of people betting against it, but that hasn't stopped the bulls from...
Read More
There are thousands of people betting against it, but that hasn't stopped the bulls from celebrating some incredible gains... Read More
Read More
